Clostridium tetani: Tetanus Toxin, Symptoms, Diagnosis, Prevention

A farmer comes to the clinic because he cannot open his mouth properly. More than a week ago he stepped on a nail in his field. The small wound has almost healed, so he did not think it mattered. Now his jaw feels tight, his face is fixed in a strange stiff grin, and his neck and back muscles are becoming rigid. He has had no tetanus vaccine.

What looks like a minor healed wound has let a spore-forming organism deliver one of the most powerful toxins in biology straight into his nervous system. The wound is not the problem anymore. The toxin already traveling up his nerves is. This is tetanus, caused by Clostridium tetani.

Introduction

Clostridium tetani is an obligate anaerobic, gram-positive rod with a terminal, round spore that gives it a drumstick appearance. It is the cause of tetanus, a vaccine-preventable disease that classically follows a puncture wound from a contaminated object, such as a nail. Tetanus is a toxin-mediated disease: the organism stays at the wound, but the toxin it makes travels to the nervous system and causes severe skeletal muscle spasms and autonomic disturbance. One idea organizes this whole topic: the disease is caused by the toxin, not by tissue invasion, so almost everything, the symptoms, the diagnosis, and the prevention, follows from what the toxin does.

Tetanus has been known since ancient times. The organism was first isolated by Kitasato in 1889.

Pathogenesis

Mode of transmission

C. tetani lives mainly as a saprophyte in soil and in animal and human feces, and infects humans only incidentally. There is no person-to-person spread.

Tetanus develops when C. tetani spores are introduced into tissue, usually through a wound: a laceration, a deep puncture, a crush injury, a burn, or a surgical or injection site. The spores themselves do no harm in healthy, well-oxygenated tissue. The danger begins when the wound contains dead tissue, foreign material, or poor blood supply. These low-oxygen conditions let the spores germinate into growing bacteria, which then produce the toxin. This is why deep puncture wounds and dirty, ragged wounds are far more dangerous than clean, shallow cuts: they create the anaerobic pocket the organism needs.

Neonatal tetanus

Neonatal tetanus is tetanus in a newborn, and it remains an important cause of infant death in low-resource settings. It happens when spores enter through the umbilical stump, usually when the cord is cut with an unsterile instrument or when contaminated material (in some traditional practices, soil, dung, or ash) is applied to the stump. The baby is born normal, then develops poor feeding and inability to suck, followed by stiffness and spasms in the first two weeks of life.

Neonatal tetanus is almost entirely preventable. The key is maternal immunization: giving tetanus toxoid to the mother during pregnancy produces antibodies that cross the placenta and protect the newborn. Clean delivery and clean cord care complete the prevention. Because the mother's antibodies protect the baby, neonatal tetanus is a marker of gaps in maternal vaccination coverage.

Virulence Factors

C. tetani produces two exotoxins, tetanolysin and tetanospasmin. Tetanospasmin is the one that causes disease.

Tetanolysin is an oxygen-labile hemolysin, related to the oxygen-labile hemolysins of C. perfringens, Streptococcus pyogenes, and Streptococcus pneumoniae. Its role is local: it damages viable tissue around the wound, which lowers the oxygen level further and improves conditions for the organism to grow. It does not cause the clinical features of tetanus.

Tetanospasmin (tetanus toxin) is the neurotoxin responsible for every clinical feature of tetanus. It is plasmid-coded and is released when the bacteria lyse after growing in the anaerobic wound. Two properties matter for exams and for understanding the disease. First, it is one of the most potent toxins known by weight. Second, it is antigenic: it can be neutralized by antitoxin (the basis of treatment with tetanus immunoglobulin), and its inactivated toxoid form is what the tetanus vaccine is made from. This single fact, that the toxin is antigenic, is why tetanus is both treatable with antitoxin and preventable by vaccine.

Mechanism of Tetanus Toxin

Tetanospasmin acts in a clear sequence. Following the sequence is the fastest way to understand every symptom.

1. Binding and entry. The toxin binds to polysialoganglioside receptors on the endings of motor neurons at the wound. This lets it enter the nerve.
2. Retrograde transport. Inside the axon, the toxin travels backward (retrograde), from the peripheral nerve ending up toward the spinal cord and brainstem. It moves along the nerve, not through the blood, which is why the shortest nerves are reached first.
3. Crossing to inhibitory neurons. In the spinal cord, the toxin moves from the motor neuron into the terminals of inhibitory interneurons nearby.
4. Blocking inhibition. The toxin is a protease. It cleaves a protein (synaptobrevin/VAMP) that inhibitory neurons need to release their neurotransmitters. This blocks the release of glycine and GABA, the two main inhibitory neurotransmitters.

Figure: Route of tetanus toxin, from entry into an α-motor neuron to its site of action in an inhibitory neuron in the central nervous system (CNS).(Image source: sciencedirect.com)

Why does blocking inhibition cause rigid, spasming muscles?

Normally, motor neurons are held in check by constant inhibitory signals (glycine and GABA) from interneurons. This braking system stops muscles from over-contracting and lets opposing muscle groups relax when one contracts. Tetanospasmin removes the brakes. With no inhibition, motor neurons fire continuously and uncontrollably. Both flexor and extensor muscles contract at the same time, with nothing to relax them. The result is sustained rigidity and painful spasms. This is spastic paralysis: the muscle is locked in contraction, not weak and floppy.

This also explains the order of symptoms. The toxin reaches the shortest nerves first, so the muscles of the jaw and face are affected earliest. That is why lockjaw (trismus) and the fixed grin (risus sardonicus) are usually the first signs, before the trunk and limbs.

Figure: Mechanism of action of tetanus toxin

Flaccid paralysis means the muscle cannot contract, so it stays weak and floppy. Spastic paralysis means the muscle is locked in contraction, so it stays rigid and goes into painful spasms. Tetanus causes spastic paralysis.

This is the key contrast with botulism. Both C. tetani and C. botulinum make neurotoxins that block neurotransmitter release, and both toxins cleave SNARE proteins. The difference is location. Botulinum toxin acts at the neuromuscular junction and blocks the release of acetylcholine, so muscles cannot contract, giving flaccid paralysis. Tetanus toxin acts in the spinal cord and blocks the release of inhibitory neurotransmitters, so muscles cannot relax, giving spastic paralysis. Same type of molecular action, opposite clinical result, because of where the toxin acts.

Clinical manifestations of Tetanus

The incubation period of tetanus is usually about 6 to 10 days, but it can be shorter or longer. A shorter incubation period means the toxin reached the nervous system faster and predicts more severe disease and a worse prognosis. As explained above, the muscles of the face and jaw are usually affected first because the toxin reaches the shortest nerves first.

Figure: Clinical Manifestations and Complications of Tetanus (Image source: osmosis.org)

Patients have prolonged spasms of both flexor and extensor muscles at the same time. The classic signs are:

• Trismus (lockjaw): difficulty opening the jaw, from spasm of the masseter muscles. This is usually the first sign.
• Risus sardonicus: a fixed, grimacing smile, from spasm of the facial muscles.
• Opisthotonos: backward arching of the neck and back, from spasm of the strong back muscles.
• Generalized spasms: violent, painful, whole-body muscle contractions, often triggered by minor stimuli such as noise, light, or touch. The patient stays fully conscious during these spasms, which makes them especially distressing.

Severe tetanus also causes autonomic instability: swings in blood pressure and heart rate, sweating, and fever. This autonomic disturbance, along with spasm of the respiratory muscles, is what makes severe tetanus life-threatening.

Laboratory Diagnosis

The diagnosis of tetanus is clinical. It is based on the typical picture of trismus, spasms, and rigidity in a patient with a compatible wound, and treatment must start immediately without waiting for the laboratory. Laboratory testing only provides supporting evidence and is often negative even in true tetanus, so a negative culture never rules it out. This is a "treat on suspicion" disease.

Specimen

Excised tissue bits from the necrotic depths of wounds are more reliable than wound swabs.

Gram staining

Figure: Spores of Clostridium tetani

Gram staining shows gram-positive rods with a terminal, round spore, giving the classic drumstick or tennis racket appearance. Microscopy alone is unreliable, because it cannot separate C. tetani from harmless clostridia of similar shape, such as C. tetanomorphum and C. sphenoides. Morphology suggests the organism but does not confirm it.

Culture

Culture is more reliable than microscopy.

1. Robertson cooked meat(RCM) broth : C. tetani is proteolytic, so it turns the meat particles black and produces a foul odor.
2. Blood agar with polymyxin B: C. tetani produces characteristic swarming growth (a fine film across the plate) when incubated anaerobically at 35–37°C for 24 to 48 hours.

Toxigenicity Test

As pathogenesis of tetanus is toxin mediated, the association of the isolated organism can only be established when its toxin production is demonstrated. Toxigenicity can be detected by both in vitro and in vivo methods.

1. In vitro hemolysis inhibition test: C. tetani produces hemolysis on blood agar which is inhibited by adding antitoxin. This test indicates the production of tetanolysin only but not tetanospasmin.
2. In vivo mouse inoculation test: RCM broth with black turbid growth is injected into the root of the tail of a test mouse. The test animal develops stiffness which begins with the tail and progresses to involve the hind limbs on the inoculated side- the other limb-trunk-forelimbs. Death occurs within two days. This test indicates the production of tetanospasmin.

Treatment of tetanus

Treatment has four aims, and they follow directly from the pathogenesis.

1. Neutralize toxin that has not yet entered nerves. Give human tetanus immunoglobulin (TIG) as soon as possible. Antitoxin can only neutralize toxin that is still free in the circulation or wound. It cannot reverse toxin that has already entered the nervous system, which is why early treatment matters and why recovery takes weeks (the body must grow new nerve terminals). This is the direct clinical use of the fact that tetanospasmin is antigenic.

2. Stop more toxin from being made. Debride the wound to remove dead tissue and the anaerobic pocket. Give an antibiotic to kill the organism. Metronidazole is the preferred agent. Penicillin is an alternative but is used with more caution because it can act as a GABA antagonist and may add to the spasms. Antibiotics are supportive: they stop further toxin production but do nothing to the toxin already released.

3. Control spasms and support the patient. Manage the patient in a quiet, dark environment to reduce triggering stimuli, and use muscle relaxants and sedation to control spasms. Severe cases need airway protection and ventilatory support, because spasm of the respiratory muscles can be fatal.

4. Start active immunization. Surviving tetanus does not produce immunity, because the amount of toxin that causes disease is too small to immunize. Every patient must be given tetanus toxoid to build lasting protection for the future.

Prevention of tetanus

Prevention is the most important part of the whole topic, because established tetanus is hard to treat and often fatal, while it is almost completely preventable.

Active immunization (tetanus toxoid). The vaccine is made from the toxoid, the inactivated toxin. It produces antibodies that neutralize tetanospasmin. It is given in childhood (as part of combined vaccines such as DTP) with booster doses, because immunity fades over time.

Wound management and post-exposure prophylaxis. When a patient presents with a wound, the decision to give toxoid, TIG, or both depends on two things: how clean or dirty the wound is, and the patient's vaccination history.

The logic: toxoid gives long-term active protection but takes time to work, while TIG gives immediate passive protection for a patient who has no existing antibodies and a dangerous wound. A patient who is already fully immunized has protective antibodies and usually needs only a booster, if any.

Maternal immunization prevents neonatal tetanus, as described above.

How to Remember

Key exam facts in one table

Where Students Get Confused

References and further readings

• Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.
• Procop, G. W., & Koneman, E. W. (2017). Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th ed.). Wolters Kluwer.
• Carroll, K. C., Pfaller, M. A., et al. (2020). Murray's Medical Microbiology (9th ed.). Elsevier.
• World Health Organization. (2017). Tetanus vaccines: WHO position paper. Weekly Epidemiological Record, 92(6), 53–76.
• World Health Organization. Maternal and neonatal tetanus elimination (MNTE). WHO fact sheet